623 related articles for article (PubMed ID: 30328165)
1. Acute myeloid leukemia: 2019 update on risk-stratification and management.
Estey EH
Am J Hematol; 2018 Oct; 93(10):1267-1291. PubMed ID: 30328165
[TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukemia: 2013 update on risk-stratification and management.
Estey EH
Am J Hematol; 2013 Apr; 88(4):318-27. PubMed ID: 23526416
[TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukemia: 2014 update on risk-stratification and management.
Estey EH
Am J Hematol; 2014 Nov; 89(11):1063-81. PubMed ID: 25318680
[TBL] [Abstract][Full Text] [Related]
4. Digital droplet PCR-based absolute quantification of pre-transplant NPM1 mutation burden predicts relapse in acute myeloid leukemia patients.
Bill M; Grimm J; Jentzsch M; Kloss L; Goldmann K; Schulz J; Beinicke S; Häntschel J; Cross M; Vucinic V; Pönisch W; Behre G; Franke GN; Lange T; Niederwieser D; Schwind S
Ann Hematol; 2018 Oct; 97(10):1757-1765. PubMed ID: 29785446
[TBL] [Abstract][Full Text] [Related]
5. Innovative strategies for adverse karyotype acute myeloid leukemia.
Blum S; Greve G; Lübbert M
Curr Opin Hematol; 2017 Mar; 24(2):89-98. PubMed ID: 28099271
[TBL] [Abstract][Full Text] [Related]
6. Counterpoint: Standard vs Investigational Agents as Upfront Treatment for High-Risk AML.
Brunner AM; Stock W
Oncology (Williston Park); 2017 Mar; 31(3):190, 192. PubMed ID: 28299756
[No Abstract] [Full Text] [Related]
7. Point: Standard vs Investigational Agents as Upfront Treatment for High-Risk AML.
Schiffer CA
Oncology (Williston Park); 2017 Mar; 31(3):190-1. PubMed ID: 28299755
[No Abstract] [Full Text] [Related]
8. Management of AML: who do we really cure?
Liesveld J
Leuk Res; 2012 Dec; 36(12):1475-80. PubMed ID: 22938830
[TBL] [Abstract][Full Text] [Related]
9. [Acute leukemia in adults].
Eigendorff E; Hochhaus A
Pathologe; 2015 Sep; 36(5):503-17; quiz 518-9. PubMed ID: 26314268
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukemia.
Rubnitz JE; Gibson B; Smith FO
Pediatr Clin North Am; 2008 Feb; 55(1):21-51, ix. PubMed ID: 18242314
[TBL] [Abstract][Full Text] [Related]
11. Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT.
Brands-Nijenhuis AV; Labopin M; Schouten HC; Volin L; Socié G; Cornelissen JJ; Huynh A; Ljungman P; Malard F; Esteve J; Nagler A; Mohty M
Haematologica; 2016 Feb; 101(2):248-55. PubMed ID: 26589909
[TBL] [Abstract][Full Text] [Related]
12. Acute myeloid leukemia.
Stone RM; O'Donnell MR; Sekeres MA
Hematology Am Soc Hematol Educ Program; 2004; ():98-117. PubMed ID: 15561679
[TBL] [Abstract][Full Text] [Related]
13. Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant.
Ahn JS; Kim JY; Kim HJ; Kim YK; Lee SS; Jung SH; Yang DH; Lee JJ; Kim NY; Choi SH; Minden MD; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Kim SH; Kim DD
Ann Hematol; 2016 Jan; 95(2):301-10. PubMed ID: 26537612
[TBL] [Abstract][Full Text] [Related]
14. Acute myeloid leukaemia in adults.
Ferrara F; Schiffer CA
Lancet; 2013 Feb; 381(9865):484-95. PubMed ID: 23399072
[TBL] [Abstract][Full Text] [Related]
15. Progress in acute myeloid leukemia.
Kadia TM; Ravandi F; O'Brien S; Cortes J; Kantarjian HM
Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):139-51. PubMed ID: 25441110
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and Therapy of Acute Myeloid Leukemia in the Era of Molecular Risk Stratification.
Komanduri KV; Levine RL
Annu Rev Med; 2016; 67():59-72. PubMed ID: 26473413
[TBL] [Abstract][Full Text] [Related]
17. Molecular characteristics therapy in AML.
Radich GP
Clin Adv Hematol Oncol; 2009 Jun; 7(6):11-4. PubMed ID: 19645131
[No Abstract] [Full Text] [Related]
18. Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?
Ferrara F
Hematol Oncol; 2014 Mar; 32(1):1-9. PubMed ID: 23512815
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic stem cell transplant may improve the outcome of adult patients with inv(16) acute myeloid leukemia in first complete remission with poor molecular responses to chemotherapy.
Qin YZ; Xu LP; Chen H; Jiang Q; Wang Y; Jiang H; Zhang XH; Han W; Chen YH; Wang FR; Wang JZ; Zhu HH; Liu YR; Jiang B; Liu KY; Huang XJ
Leuk Lymphoma; 2015; 56(11):3116-23. PubMed ID: 25804769
[TBL] [Abstract][Full Text] [Related]
20. Comparable outcomes of haploidentical, 10/10 and 9/10 unrelated donor transplantation in adverse karyotype AML in first complete remission.
Lorentino F; Labopin M; Bernardi M; Ciceri F; Socié G; Cornelissen JJ; Esteve J; Ruggeri A; Volin L; Yacoub-Agha I; Craddock C; Passweg J; Blaise D; Gedde-Dahl T; Poiani M; Fegueux N; Mohty M; Nagler A;
Am J Hematol; 2018 Oct; 93(10):1236-1244. PubMed ID: 30058714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
